ATE178410T1 - Verfahren zur hochempfindlichen dosierung von herztroponin - i - Google Patents

Verfahren zur hochempfindlichen dosierung von herztroponin - i

Info

Publication number
ATE178410T1
ATE178410T1 AT96901825T AT96901825T ATE178410T1 AT E178410 T1 ATE178410 T1 AT E178410T1 AT 96901825 T AT96901825 T AT 96901825T AT 96901825 T AT96901825 T AT 96901825T AT E178410 T1 ATE178410 T1 AT E178410T1
Authority
AT
Austria
Prior art keywords
highly sensitive
cardiac troponin
sensitive dosing
dosing
cardiac
Prior art date
Application number
AT96901825T
Other languages
English (en)
Inventor
Charles Calzolari
Odile Flecheux
Bernard Pau
Original Assignee
Pasteur Sanofi Diagnostics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pasteur Sanofi Diagnostics filed Critical Pasteur Sanofi Diagnostics
Application granted granted Critical
Publication of ATE178410T1 publication Critical patent/ATE178410T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/577—Immunoassay; Biospecific binding assay; Materials therefor involving monoclonal antibodies binding reaction mechanisms characterised by the use of monoclonal antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • External Artificial Organs (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Steroid Compounds (AREA)
AT96901825T 1995-01-19 1996-01-19 Verfahren zur hochempfindlichen dosierung von herztroponin - i ATE178410T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9500597A FR2729759A1 (fr) 1995-01-19 1995-01-19 Procede de dosage ultrasensible de la troponine i cardiaque

Publications (1)

Publication Number Publication Date
ATE178410T1 true ATE178410T1 (de) 1999-04-15

Family

ID=9475293

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96901825T ATE178410T1 (de) 1995-01-19 1996-01-19 Verfahren zur hochempfindlichen dosierung von herztroponin - i

Country Status (13)

Country Link
EP (1) EP0804736B1 (de)
JP (1) JP3558643B2 (de)
KR (1) KR100237239B1 (de)
CN (1) CN1105306C (de)
AT (1) ATE178410T1 (de)
AU (1) AU703944B2 (de)
BR (1) BR9607164A (de)
DE (1) DE69601922T2 (de)
DK (1) DK0804736T3 (de)
ES (1) ES2131929T3 (de)
FR (1) FR2729759A1 (de)
GR (1) GR3030113T3 (de)
WO (1) WO1996022535A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0871887B1 (de) * 1995-06-07 2007-03-28 BioVeris Corporation Elektrochemilumineszenz-enzymimmunoassay
ATE494549T1 (de) * 2003-04-16 2011-01-15 Ono Pharmaceutical Co Screening-verfahren für heilmittel gegen herzkrankheit und medizinische zusammensetzung zur behandlung von herzkrankheit
CN101105497B (zh) * 2006-07-13 2011-10-19 上海凯创生物技术有限公司 一种检测心肌肌钙蛋白i的试剂盒及其制备方法
US20110136141A1 (en) * 2009-12-03 2011-06-09 Abbott Laboratories Peptide reagents and method for inhibiting autoantibody antigen binding
CN102183657B (zh) * 2011-02-24 2014-02-05 南京基蛋生物科技有限公司 一种依赖聚苯乙烯纳米粒大幅度增加化学发光磁酶免疫灵敏度的方法
JPWO2013094080A1 (ja) * 2011-12-20 2015-04-27 パナソニックヘルスケア株式会社 ヒト心筋由来トロポニンｉに特異的にかつ速やかに結合できる組み換えタンパク質
US8603760B2 (en) 2011-12-20 2013-12-10 Panasonic Corporation Recombinant protein capable of binding specifically and quickly to troponin I derived from human myocardium
WO2013099043A1 (ja) * 2011-12-26 2013-07-04 パナソニック株式会社 ヒト心筋由来トロポニンｉに特異的にかつ速やかに結合できる組み換えタンパク質
CN102735848A (zh) * 2012-07-05 2012-10-17 北京源德生物医学工程有限公司 一种人肌钙蛋白i酶促化学发光免疫检测方法和试剂盒
CA2961340C (en) 2014-09-26 2023-10-17 Somalogic, Inc. Cardiovascular risk event prediction and uses thereof
CN105132383A (zh) * 2015-07-25 2015-12-09 大庆麦伯康生物技术有限公司 抗cTnI单克隆抗体产生的杂交瘤
JP6651794B2 (ja) * 2015-11-05 2020-02-19 富士レビオ株式会社 心筋トロポニンｉ測定試薬及び方法
EP3438666B1 (de) * 2016-03-31 2020-10-14 ABSOLOGY Co., Ltd Verfahren zur quantifizierung hochsensitiver biomarker mit fotooxidationsamplifikation
CN110031635A (zh) * 2019-05-16 2019-07-19 杭州普鲁米生物科技有限公司 闪光型均相化学发光技术检测心肌肌钙蛋白i/t的方法
CN112014573B (zh) * 2020-08-25 2023-08-08 武汉生之源生物科技股份有限公司 一种人全血样本中肌钙蛋白i的高敏测定试剂盒的制备方法及试剂盒

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0116454B1 (de) * 1983-02-11 1987-04-29 National Research Development Corporation Erhöhte lumineszierende oder luminometrische Prüfung
US4931223A (en) * 1986-07-24 1990-06-05 Tropix, Inc. Methods of using chemiluminescent 1,2-dioxetanes
US5336596A (en) * 1991-12-23 1994-08-09 Tropix, Inc. Membrane for chemiluminescent blotting applications
DE69420556T2 (de) * 1993-05-17 2000-03-23 Fortron Bioscience, Inc. Assay für troponin i aus dem herzmuskel

Also Published As

Publication number Publication date
MX9705411A (es) 1997-11-29
KR19980701608A (ko) 1998-06-25
ES2131929T3 (es) 1999-08-01
GR3030113T3 (en) 1999-07-30
DE69601922D1 (de) 1999-05-06
EP0804736B1 (de) 1999-03-31
WO1996022535A1 (fr) 1996-07-25
DE69601922T2 (de) 1999-10-07
AU4625196A (en) 1996-08-07
KR100237239B1 (ko) 2000-01-15
JP3558643B2 (ja) 2004-08-25
AU703944B2 (en) 1999-04-01
JPH10512672A (ja) 1998-12-02
CN1176002A (zh) 1998-03-11
CN1105306C (zh) 2003-04-09
FR2729759A1 (fr) 1996-07-26
BR9607164A (pt) 1997-11-11
DK0804736T3 (da) 1999-10-18
EP0804736A1 (de) 1997-11-05

Similar Documents

Publication Publication Date Title
ATE178410T1 (de) Verfahren zur hochempfindlichen dosierung von herztroponin - i
DE69818304D1 (de) Verfahren zur reduktion von oxiranyl-epothilonen zu olefinischen epothilonen
DE3861783D1 (de) Verfahren zur gasphasensilylierung von photoresisten.
DE69529936D1 (de) Verfahren zur Quantifizierung von spezifischen Verbindungen
EP0093782A4 (de) Verfahren zum biologischen erzeugen von amiden.
DE3587360D1 (de) Verfahren zur herstellung von chimaerischen monoklonalen antikoerpern.
DE69116921D1 (de) Verfahren zur Reinigung von monoklonalen Antikörpern
DE3874028D1 (de) Verfahren zur justierung von photomasken.
DE68913251D1 (de) Verfahren zur Verringerung der Heterogenität von monoklonalen Antikörpern.
DE68902321D1 (de) Verfahren zum bestimmen der strahlungsverluste von faserverbindungen.
DE3578942D1 (de) Verfahren zum haerten von gelatine.
ATE54452T1 (de) Verfahren zur herstellung von penemen.
DE68910729D1 (de) Verfahren für die Flockung von Schlamm.
DE3480923D1 (de) Verfahren zur c-methylierung von 2-methylbutyraten.
DE3575713D1 (de) Verfahren zur gewinnung von c2+-, c3+- oder von c4+- kohlenwasserstoffen.
DE69021159D1 (de) Verfahren zum immunochemischen Bestimmen von Haptenen.
ATA154783A (de) Verfahren zur deponierung von sonderabfaellen
AT375640B (de) Verfahren zur herstellung von substituierten 2-azetidinonderivaten
DE69635873D1 (de) Verfahren zur Massenproduktion von Taxol mittels Induktion
ATE5719T1 (de) Verfahren zur herstellung von 3-picolin.
DE69324039D1 (de) Verfahren zur kaseinfertigung von leder
AT375401B (de) Verfahren zur herstellung von betonbewehrungsstahl
DE3889232D1 (de) Verfahren zum quantitativen Nachweis von Sauerstoff.
DE3763677D1 (de) Verfahren zur vermehrung von mikropflanzen durch erhoehte mehrfachtriebbildung.
ATA196391A (de) Verfahren zur gewinnung von platin hoher reinheit

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEFA Change of the company name
EEFA Change of the company name